TRPV1 is expressed in a subpopulation of myelinated Ad and unmyelinated C-fibers. TRPV1 + fibers are essential for the transmission of nociceptive thermal stimuli and for the establishment and maintenance of inflammatory hyperalgesia. We have previously shown that high-power, short-duration pulses from an infrared diode laser are capable of predominantly activating cutaneous TRPV1 + Ad-fibers. Here we show that stimulating either subtype of TRPV1 + fiber in the paw during carrageenan-induced inflammation or following hind-paw incision elicits pronounced hyperalgesic responses, including prolonged paw guarding. The ultrapotent TRPV1 agonist resiniferatoxin (RTX) dose-dependently deactivates TRPV1 + fibers and blocks thermal nociceptive responses in baseline or inflamed conditions. Injecting sufficient doses of RTX peripherally renders animals unresponsive to laser stimulation even at the point of acute thermal skin damage. In contrast, Trpv1À/À mice, which are generally unresponsive to noxious thermal stimuli at lower power settings, exhibit withdrawal responses and inflammation-induced sensitization using high-power, short duration Ad stimuli. In rats, systemic morphine suppresses paw withdrawal, inflammatory guarding, and hyperalgesia in a dose-dependent fashion using the same Ad stimuli. The qualitative intensity of Ad responses, the leftward shift of the stimulus-response curve, the increased guarding behaviors during carrageenan inflammation or after incision, and the reduction of Ad responses with morphine suggest multiple roles for TRPV1 + Ad fibers in nociceptive processes and their modulation of pathological pain conditions.
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Introduction
Detection of impending or actual tissue damage is essential to the survival of an organism and depends upon primary afferent nociceptors responsive to a wide range of stimulus intensities and modalities [2, 4] . For thermal stimuli in the noxious range, detection occurs through afferent fibers expressing TRPV1, a calcium and sodium permeable ion channel gated by heat, low pH, and a variety of endogenous ligands [20, 54] . Experimental data from recordings of primary afferents and behavioral studies in mouse, rat, monkey, and human, as well as responses of cloned TRPV1 in heterologous expression systems, support the notion that channel opening, ion flux and action potential generation occur at heat intensities coincident with increased afferent firing and behavioral response [2, [8] [9] [10] 14, 61] . However, the convergence of afferent fiber molecular properties and physiological classifications with clinical pain disorders and actions of therapeutic agents is an evolving subject of investigation. Classification based on recordings from monkey primary afferents has delineated 2 major sets of thermo-nociceptive fibers: the first is activated by adequate concentrations of the TRPV1 agonist capsaicin and nociceptive thermal stimuli and is termed type II Ad mechanoheat (AMH) fibers. A second population of high thermal threshold nociceptors is relatively insensitive to capsaicin and is activated only at stimulus intensities supramaximal for 
